Research paper efficacy and safety of telitacicept combined with standard therapy for lupus nephritis: a single-center real-world study

Telitacicept combined with standard therapy demonstrated significant efficacy in LN with an acceptable safety profile, achieving high response rates, reduced proteinuria, improved immunological parameters, and substantial glucocorticoid-sparing effects.